CN110934770A - Pepper extraction stock solution mask and production process thereof - Google Patents
Pepper extraction stock solution mask and production process thereof Download PDFInfo
- Publication number
- CN110934770A CN110934770A CN201811113336.3A CN201811113336A CN110934770A CN 110934770 A CN110934770 A CN 110934770A CN 201811113336 A CN201811113336 A CN 201811113336A CN 110934770 A CN110934770 A CN 110934770A
- Authority
- CN
- China
- Prior art keywords
- extract
- oligopeptide
- phase
- propylene glycol
- sodium hyaluronate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a phthalocyanine raw liquid mask and a production process thereof, wherein the mask comprises a phase A raw material of xanthan gum, propylene glycol, sclerotium rolfsii gum, water, sodium hyaluronate and p-hydroxyacetophenone, and a phase B raw material of propylene glycol, trehalose, glycerol, glyceryl polyether-26, polyglycerol-10, erythritol, aloe extract, butanediol, caprylyl hydroximic acid, sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, mint leaf extract, pelargonium graveolens extract, golden chamomile extract, radix sophorae flavescentis extract, aloe barbadensis leaf extract and tripeptide-2; the facial mask prepared from the raw materials according to the corresponding preparation process has the effects of lifting and reshaping facial contours and reducing fine lines, can also increase skin immunity, can exert defense capacity, recover the original young structure and moisturizing function of skin tissue collagen, and improve compactness, elasticity and bright luster.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a facial mask prepared from a raw liquid of a phthalocyanine extract and a production process.
Background
The mask is a carrier of beauty care products, and the existing masks made of powder blend, kaolin, non-woven fabrics, silk masks, tencel masks, biological fiber masks and non-woven fabrics masks are widely used and have various effects. It is a category of skin care products. The most basic and important purpose is to make up the still insufficient cleaning work of makeup removal and face washing, and other maintenance functions such as water replenishing and moisturizing, whitening, anti-aging, grease balancing and the like are realized by matching with other essential components on the basis. However, the existing facial mask on the market has a single function, usually has the functions of moisturizing and moisturizing, but cannot repair the fine wrinkles on the face, or can reduce the fine wrinkles on the face, but cannot improve the skin firmness; therefore, the comprehensive efficacy of the facial mask on the market at present is still lack, and the use requirements of people cannot be met.
Disclosure of Invention
The invention aims to provide a phthalocyanine raw solution facial mask and a production process thereof, which have the effects of lifting and reshaping facial contours and reducing fine wrinkles, can also increase the skin immunity function, exert the defense capability, recover the original young structure and moisture retention function of skin tissue collagen, and improve the compactness, elasticity and bright luster so as to solve the problems of incomplete efficacy and the like of the existing facial mask in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme: the peptide cyanine extraction stock solution mask comprises an A-phase raw material and a B-phase raw material, wherein the A-phase raw material is composed of the following raw materials in parts by mass: 0.1-0.5% of xanthan gum, 3.0-6.0% of propylene glycol, 0.1-0.5% of sclerotium rolfsii gum, 70.0-90.0% of water, 0.1-2.0% of sodium hyaluronate, 1.0-4.0% of ethylene glycol and 0.2-2.0% of p-hydroxyacetophenone; the phase B raw material consists of the following raw materials in parts by mass: 0.5-4.0% of propylene glycol, 0.5-2.0% of trehalose, 1.0-6.0% of glycerol, 1.0-4.0% of glyceryl polyether-26, 1.0-2.0% of polyglycerol-10, 1.0-3.0% of erythritol, 1.0-4.0% of aloe extract, 0.5-6.0% of butanediol, caprylyl hydroximic acid, 1.0-5.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 1.0-3.0% of mint leaf extract, geranium extract, chamomile extract, sophora flavescens root extract, aloe barbadensis leaf extract and 0.5-2.0% of tripeptide-2.
Preferably, the liquid phase comprises 0.1% of xanthan gum, 3.0% of propylene glycol, 0.1% of sclerotium rolfsii gum, 86.5% of water, 0.1% of sodium hyaluronate, 1.0% of ethylene glycol and 0.2% of p-hydroxyacetophenone in phase A raw materials; in the raw materials of the phase B, 0.5 percent of propylene glycol, 0.5 percent of trehalose, 1.0 percent of glycerin, 1.0 percent of glyceryl polyether-26, 1.0 percent of polyglycerol-10, 1.0 percent of erythritol, 1.0 percent of aloe extract, 0.5 percent of butanediol, caprylyl hydroximic acid, 1.0 percent of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 1.0 percent of mint leaf extract, geranium extract, golden yellow chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 0.5 percent of tripeptide-2 are added.
Preferably, the liquid phase comprises 0.5% of xanthan gum, 6.0% of propylene glycol, 0.5% of sclerotium rolfsii gum, 70.0% of water, 2.0% of sodium hyaluronate, 4.0% of ethylene glycol and 2.0% of p-hydroxyacetophenone in phase A raw materials; 4.0% of propylene glycol, 2.0% of trehalose, 6.0% of glycerol, 4.0% of glyceryl polyether-26, 2.0% of polyglycerol-10, 3.0% of erythritol, 4.0% of aloe extract, 6.0% of butanediol, caprylyl hydroxamic acid, 5.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 3.0% of mint leaf extract, pelargonium graveolens extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 2.0% of tripeptide-2 in the raw materials of the phase B.
Preferably, the liquid phase comprises 0.2% of xanthan gum, 3.0% of propylene glycol, 0.1% of sclerotium rolfsii gum, 78.4% of water, 2.0% of sodium hyaluronate, 3.0% of ethylene glycol and 0.2% of p-hydroxyacetophenone in phase A raw materials; in the raw materials of the phase B, 1.0% of propylene glycol, 2.0% of trehalose, 1.0% of glycerol, 2.0% of glyceryl polyether-26, 1.0% of polyglycerol-10, 1.0% of erythritol, 3.0% of aloe extract, 0.5% of butanediol, caprylyl hydroximic acid, 1.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 2.0% of mint leaf extract, geranium extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 0.5% of tripeptide-2 are added.
The invention provides another technical scheme as follows: a production process of a facial mask with a raw liquid of a phthalocyanine extract comprises the following steps:
s1: heating xanthan gum, propylene glycol, sclerotium rolfsii gum, water, sodium hyaluronate, ethylene glycol and p-hydroxyacetophenone in the phase A raw materials to 95 ℃ for heat preservation and sterilization, and cooling to below 45 ℃ after heat preservation for 30 minutes;
s2: respectively adding B-phase raw materials including propylene glycol, trehalose, glycerol, glyceryl polyether-26, polyglycerol-10, erythritol, aloe extract, butanediol, caprylyl hydroximic acid, sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, mint leaf extract, pelargonium graveolens extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and tripeptide-2 into S1, and uniformly stirring;
s3: and (5) cooling the solution obtained in the step S2, and discharging after the solution is qualified through inspection.
Preferably, the solution obtained by uniformly stirring in S2 is a colorless transparent liquid, the pH value of the solution is 5.5-7 at the normal temperature of 25 ℃, the heat-resistant temperature of the solution is 45 ℃, and the cold-resistant temperature of the solution is-5 ℃.
Compared with the prior art, the invention has the beneficial effects that:
the invention provides a phthalocyanine raw liquid mask and a production process, wherein a phase A raw material xanthan gum, propylene glycol, sclerotium rolfsii gum, water, sodium hyaluronate and p-hydroxyacetophenone are selected, and a phase B raw material, namely propylene glycol, trehalose, glycerol, glyceryl polyether-26, polyglycerol-10, erythritol, an aloe extract, butanediol, caprylyl hydroximic acid, sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, a mint leaf extract, a pelargonium graveolens extract, a chamomile extract, a radix sophorae flavescentis extract, an aloe vera leaf extract and a tripeptide-2 are selected; the facial mask prepared from the raw materials has the effects of lifting and reshaping facial contours and reducing fine wrinkles, can also increase skin immunity, can exert defense capacity, recover the original young structure and moisturizing function of skin tissue collagen, and improve firmness, elasticity and bright luster.
Detailed Description
The following examples will explain the present invention in detail, however, the present invention is not limited thereto. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the embodiment of the invention: the provided peptide cyanine extraction stock solution mask comprises an A-phase raw material and a B-phase raw material, wherein the A-phase raw material comprises the following raw materials in parts by mass: 0.1-0.5% of xanthan gum, 3.0-6.0% of propylene glycol, 0.1-0.5% of sclerotium rolfsii gum, 70.0-90.0% of water, 0.1-2.0% of sodium hyaluronate, 1.0-4.0% of ethylene glycol and 0.2-2.0% of p-hydroxyacetophenone; the phase B raw material consists of the following raw materials in parts by mass: 0.5-4.0% of propylene glycol, 0.5-2.0% of trehalose, 1.0-6.0% of glycerol, 1.0-4.0% of glyceryl polyether-26, 1.0-2.0% of polyglycerol-10, 1.0-3.0% of erythritol, 1.0-4.0% of aloe extract, 0.5-6.0% of butanediol, caprylyl hydroximic acid, 1.0-5.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 1.0-3.0% of mint leaf extract, geranium extract, chamomile extract, sophora flavescens root extract, aloe barbadensis leaf extract and 0.5-2.0% of tripeptide-2.
The first embodiment is as follows:
based on the above description: taking 0.1% of xanthan gum, 3.0% of propylene glycol, 0.1% of sclerotium rolfsii gum, 86.5% of water, 0.1% of sodium hyaluronate, 1.0% of ethylene glycol and 0.2% of p-hydroxyacetophenone in the phase A raw materials; taking 0.5% of propylene glycol, 0.5% of trehalose, 1.0% of glycerol, 1.0% of glyceryl polyether-26, 1.0% of polyglycerol-10, 1.0% of erythritol, 1.0% of aloe extract, 0.5% of butanediol, caprylyl hydroximic acid, 1.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 1.0% of mint leaf extract, pelargonium graveolens extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 0.5% of tripeptide-2 in the raw materials of the phase B.
The raw materials are prepared according to the following process:
the method comprises the following steps: taking 0.1% of xanthan gum, 3.0% of propylene glycol, 0.1% of sclerotium rolfsii gum, 86.5% of water, 0.1% of sodium hyaluronate, 1.0% of ethylene glycol and 0.2% of p-hydroxyacetophenone in the phase A raw materials, firstly heating to 95 ℃, preserving heat and sterilizing, preserving heat for 30 minutes, and then cooling to below 45 ℃;
step two: respectively adding 0.5% of propylene glycol, 0.5% of trehalose, 1.0% of glycerol, 1.0% of glyceryl polyether-26, 1.0% of polyglycerol-10, 1.0% of erythritol, 1.0% of aloe extract, 0.5% of butanediol, caprylyl hydroxamic acid, 1.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 1.0% of mint leaf extract, pelargonium graveolens extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 0.5% of tripeptide-2 in the phase B raw materials, and uniformly stirring;
step three: and (5) cooling the solution obtained in the step two, and discharging after the solution is qualified.
Example two:
taking 0.5% of xanthan gum, 6.0% of propylene glycol, 0.5% of sclerotium rolfsii gum, 70.0% of water, 2.0% of sodium hyaluronate, 4.0% of ethylene glycol and 2.0% of p-hydroxyacetophenone in the phase A raw materials; 4.0% of propylene glycol, 2.0% of trehalose, 6.0% of glycerol, 4.0% of glyceryl polyether-26, 2.0% of polyglycerol-10, 3.0% of erythritol, 4.0% of aloe extract, 6.0% of butanediol, caprylyl hydroxamic acid, 5.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 3.0% of mint leaf extract, pelargonium graveolens extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 2.0% of tripeptide-2 in the raw materials of the phase B.
The raw materials are prepared according to the following process:
the method comprises the following steps: taking 0.5% of xanthan gum, 6.0% of propylene glycol, 0.5% of sclerotium rolfsii gum, 70.0% of water, 2.0% of sodium hyaluronate, 4.0% of ethylene glycol and 2.0% of p-hydroxyacetophenone in the phase A raw materials, firstly heating to 95 ℃, preserving heat, sterilizing, preserving heat for 30 minutes, and then cooling to below 45 ℃;
step two: respectively adding 4.0% of propylene glycol, 2.0% of trehalose, 6.0% of glycerol, 4.0% of glyceryl polyether-26, 2.0% of polyglycerol-10, 3.0% of erythritol, 4.0% of aloe extract, 6.0% of butanediol, caprylyl hydroxamic acid, 5.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 3.0% of mint leaf extract, pelargonium graveolens extract, chamomile extract, bitter ginseng root extract, aloe vera leaf extract and 2.0% of tripeptide-2 in the phase B raw materials, and uniformly stirring;
step three: and (5) cooling the solution obtained in the step two, and discharging after the solution is qualified.
Example three:
taking 0.2% of xanthan gum, 3.0% of propylene glycol, 0.1% of sclerotium rolfsii gum, 78.4% of water, 2.0% of sodium hyaluronate, 3.0% of ethylene glycol and 0.2% of p-hydroxyacetophenone in the phase A raw materials; in the raw materials of the phase B, 1.0% of propylene glycol, 2.0% of trehalose, 1.0% of glycerol, 2.0% of glyceryl polyether-26, 1.0% of polyglycerol-10, 1.0% of erythritol, 3.0% of aloe extract, 0.5% of butanediol, caprylyl hydroximic acid, 1.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 2.0% of mint leaf extract, geranium extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 0.5% of tripeptide-2 are added.
The raw materials are prepared according to the following process:
the method comprises the following steps: taking 0.2% of xanthan gum, 3.0% of propylene glycol, 0.1% of sclerotium rolfsii gum, 78.4% of water, 2.0% of sodium hyaluronate, 3.0% of ethylene glycol and 0.2% of p-hydroxyacetophenone in the phase A raw materials, firstly heating to 95 ℃, preserving heat, sterilizing, preserving heat for 30 minutes, and then cooling to below 45 ℃;
step two: respectively adding 1.0% of propylene glycol, 2.0% of trehalose, 1.0% of glycerol, 2.0% of glyceryl polyether-26, 1.0% of polyglycerol-10, 1.0% of erythritol, 3.0% of aloe extract, 0.5% of butanediol, caprylyl hydroxamic acid, 1.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 2.0% of mint leaf extract, pelargonium graveolens extract, chamomile extract, bitter ginseng root extract, aloe vera leaf extract and 0.5% of tripeptide-2 in the phase B raw materials, and uniformly stirring;
step three: and (5) cooling the solution obtained in the step two, and discharging after the solution is qualified.
Comparing the solutions obtained in the first, second and third examples, wherein the solutions are colorless transparent liquids, the pH value is 5.5-7 at the normal temperature of 25 ℃, the heat-resistant temperature is 45 ℃, and the cold-resistant temperature is-5 ℃; and dividing the final products obtained in the first, second and third embodiments into three groups of tests A, B, C, and carrying out experimental effect verification:
test group a: the product of example one was applied to the face of 5 middle-aged women aged about 40-45, with a cycle of use: applying the facial mask once a day for 30 consecutive days; effect feedback: within 20 minutes after application, the skin is compact and elastic, the skin on the face is not dry and astringent, and the fine wrinkles on the face are not increased.
Test group B: the product of example two was applied to the face of 5 middle-aged women aged about 40-45, with a cycle of use: applying the facial mask once a day for 30 consecutive days; effect feedback: within 20 minutes after application, the skin is compact and elastic, the skin on the face is not dry and astringent, fine lines on the face are slowly formed within one month, and compared with the situation before use, the fine line forming speed is slowed to some extent, and only a few fine lines are generated.
Test group C: the product of example three was applied to the face of 5 middle-aged women aged about 40-45, with a cycle of use: applying the facial mask once a day for 30 consecutive days; effect feedback: within 20 minutes after the application, the skin is compact and elastic, the skin on the face is not dry and astringent, the moisturizing effect can be as long as 10 hours, fine lines on the face are obviously reduced within one month, and the skin glossiness is also obviously improved.
In summary, the following steps: the face mask has the effects of lifting and reshaping the face contour and reducing the formation of fine lines, and can be obtained according to the feedback effect of a user, so that the face mask can increase the skin immunologic function, exert the defense capability, recover the original young structure and moisturizing function of skin tissue collagen, and improve the compactness, elasticity and bright luster; and it can be obtained from the feedback effect of the three groups of test A, B, C that the feedback effect of the use of the test group C is the best, i.e. the raw material ratio in the example three is the best ratio of the present invention.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. The peptide cyanine raw solution mask is characterized by comprising an A-phase raw material and a B-phase raw material, wherein the A-phase raw material is composed of the following raw materials in parts by mass: 0.1-0.5% of xanthan gum, 3.0-6.0% of propylene glycol, 0.1-0.5% of sclerotium rolfsii gum, 70.0-90.0% of water, 0.1-2.0% of sodium hyaluronate, 1.0-4.0% of ethylene glycol and 0.2-2.0% of p-hydroxyacetophenone; the phase B raw material consists of the following raw materials in parts by mass: 0.5-4.0% of propylene glycol, 0.5-2.0% of trehalose, 1.0-6.0% of glycerol, 1.0-4.0% of glyceryl polyether-26, 1.0-2.0% of polyglycerol-10, 1.0-3.0% of erythritol, 1.0-4.0% of aloe extract, 0.5-6.0% of butanediol, caprylyl hydroximic acid, 1.0-5.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 1.0-3.0% of mint leaf extract, geranium extract, chamomile extract, sophora flavescens root extract, aloe barbadensis leaf extract and 0.5-2.0% of tripeptide-2.
2. The mask of claim 1, comprising 0.1% xanthan gum, 3.0% propylene glycol, 0.1% sclerotium rolfsii gum, 86.5% water, 0.1% sodium hyaluronate, 1.0% ethylene glycol and 0.2% p-hydroxyacetophenone in phase a raw material; in the raw materials of the phase B, 0.5 percent of propylene glycol, 0.5 percent of trehalose, 1.0 percent of glycerin, 1.0 percent of glyceryl polyether-26, 1.0 percent of polyglycerol-10, 1.0 percent of erythritol, 1.0 percent of aloe extract, 0.5 percent of butanediol, caprylyl hydroximic acid, 1.0 percent of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 1.0 percent of mint leaf extract, geranium extract, golden yellow chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 0.5 percent of tripeptide-2 are added.
3. The mask of claim 1, comprising 0.5% xanthan gum, 6.0% propylene glycol, 0.5% sclerotium rolfsii gum, 70.0% water, 2.0% sodium hyaluronate, 4.0% ethylene glycol and 2.0% p-hydroxyacetophenone in phase a raw material; 4.0% of propylene glycol, 2.0% of trehalose, 6.0% of glycerol, 4.0% of glyceryl polyether-26, 2.0% of polyglycerol-10, 3.0% of erythritol, 4.0% of aloe extract, 6.0% of butanediol, caprylyl hydroxamic acid, 5.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 3.0% of mint leaf extract, pelargonium graveolens extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 2.0% of tripeptide-2 in the raw materials of the phase B.
4. The mask of claim 1, comprising 0.2% xanthan gum, 3.0% propylene glycol, 0.1% sclerotium rolfsii gum, 78.4% water, 2.0% sodium hyaluronate, 3.0% ethylene glycol and 0.2% p-hydroxyacetophenone in phase a raw material; in the raw materials of the phase B, 1.0% of propylene glycol, 2.0% of trehalose, 1.0% of glycerol, 2.0% of glyceryl polyether-26, 1.0% of polyglycerol-10, 1.0% of erythritol, 3.0% of aloe extract, 0.5% of butanediol, caprylyl hydroximic acid, 1.0% of sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, 2.0% of mint leaf extract, geranium extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and 0.5% of tripeptide-2 are added.
5. A process for producing a facial mask with a phthalocyanine raw solution according to claim 1, which comprises the following steps:
s1: heating xanthan gum, propylene glycol, sclerotium rolfsii gum, water, sodium hyaluronate, ethylene glycol and p-hydroxyacetophenone in the phase A raw materials to 95 ℃ for heat preservation and sterilization, and cooling to below 45 ℃ after heat preservation for 30 minutes;
s2: respectively adding B-phase raw materials including propylene glycol, trehalose, glycerol, glyceryl polyether-26, polyglycerol-10, erythritol, aloe extract, butanediol, caprylyl hydroximic acid, sodium hyaluronate, oligopeptide-1, oligopeptide-5, oligopeptide-2, mint leaf extract, pelargonium graveolens extract, chamomile extract, sophora flavescens root extract, aloe vera leaf extract and tripeptide-2 into S1, and uniformly stirring;
s3: and (5) cooling the solution obtained in the step S2, and discharging after the solution is qualified through inspection.
6. The process for producing the facial mask with the phthalocyanine raw solution as claimed in claim 5, wherein the solution obtained by stirring the solution in the S2 is a colorless transparent liquid, the pH value of the transparent liquid is 5.5 to 7 at the normal temperature of 25 ℃, the heat resistance temperature of the transparent liquid is 45 ℃, and the cold resistance temperature of the transparent liquid is-5 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811113336.3A CN110934770A (en) | 2018-09-25 | 2018-09-25 | Pepper extraction stock solution mask and production process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811113336.3A CN110934770A (en) | 2018-09-25 | 2018-09-25 | Pepper extraction stock solution mask and production process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110934770A true CN110934770A (en) | 2020-03-31 |
Family
ID=69905529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811113336.3A Pending CN110934770A (en) | 2018-09-25 | 2018-09-25 | Pepper extraction stock solution mask and production process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110934770A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111920728A (en) * | 2020-07-14 | 2020-11-13 | 爱西美(珠海)生物技术有限公司 | Cosmetic relieving and repairing composition and cosmetic |
| CN112057397A (en) * | 2020-09-12 | 2020-12-11 | 荣鼎(广东)生物科技有限公司 | Collagen activation stock solution cosmetic and preparation method thereof |
| CN112535652A (en) * | 2020-09-12 | 2021-03-23 | 荣鼎(广东)生物科技有限公司 | Light sensation activation stock solution and preparation method thereof |
| CN112675110A (en) * | 2021-01-08 | 2021-04-20 | 厦门力嘉诚生物科技有限公司 | Graphene ginseng mask and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104814919A (en) * | 2015-05-13 | 2015-08-05 | 朱敏 | Moisturizing anti-wrinkle mask solution, manufacturing method and moisturizing anti-wrinkle mask |
| CN108309893A (en) * | 2018-04-29 | 2018-07-24 | 无锡市科姆斯化工科技有限公司 | A kind of aloe-seaweed moisture saver mask |
-
2018
- 2018-09-25 CN CN201811113336.3A patent/CN110934770A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104814919A (en) * | 2015-05-13 | 2015-08-05 | 朱敏 | Moisturizing anti-wrinkle mask solution, manufacturing method and moisturizing anti-wrinkle mask |
| CN108309893A (en) * | 2018-04-29 | 2018-07-24 | 无锡市科姆斯化工科技有限公司 | A kind of aloe-seaweed moisture saver mask |
Non-Patent Citations (1)
| Title |
|---|
| 广州东智盟化妆品有限公司: ""臻嫩摩力肽三维嫩肤修护套组-摩力肽精粹原液面膜"", 《国产非特殊用途化妆品备案服务平台》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111920728A (en) * | 2020-07-14 | 2020-11-13 | 爱西美(珠海)生物技术有限公司 | Cosmetic relieving and repairing composition and cosmetic |
| CN112057397A (en) * | 2020-09-12 | 2020-12-11 | 荣鼎(广东)生物科技有限公司 | Collagen activation stock solution cosmetic and preparation method thereof |
| CN112535652A (en) * | 2020-09-12 | 2021-03-23 | 荣鼎(广东)生物科技有限公司 | Light sensation activation stock solution and preparation method thereof |
| CN112675110A (en) * | 2021-01-08 | 2021-04-20 | 厦门力嘉诚生物科技有限公司 | Graphene ginseng mask and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110934770A (en) | Pepper extraction stock solution mask and production process thereof | |
| CN105232442A (en) | Plant antioxidation amino acid cleanser and preparation method thereof | |
| CN110613676A (en) | Chitosan marine peptide crystal facial mask | |
| CN104173256B (en) | Compose and support replenishing water and preserving moisture emulsion | |
| CN105534845A (en) | Shampoo capable of strengthening hair and nourishing hair | |
| CN111529413A (en) | Nicotinamide capsule mask and preparation and use methods thereof | |
| CN103599007A (en) | Lotion containing aloe juice and preparation method thereof | |
| CN108721201A (en) | A kind of multiple-effect Xiu Fu treatment waxes and preparation method thereof | |
| CN113350247A (en) | Preparation method and application of hair-care plant compound | |
| CN111214430A (en) | Codonopsis pilosula and astragalus membranaceus composite Chinese herbal medicine base whitening anti-inflammatory moisturizing mask and preparation method thereof | |
| CN110237006B (en) | Skin care composition and mask | |
| CN111297787A (en) | Hyaluronic acid water-moistening mask | |
| CN106727247A (en) | A kind of anti acne of traditional Chinese medicine facial mask and preparation method thereof | |
| KR20140139930A (en) | Shampoo compoisiton for improving state of scalp and hair | |
| CN108309871B (en) | Anti-wrinkle moisturizing and water-locking essence and preparation method thereof | |
| CN111840197A (en) | Traditional Chinese medicine-based whitening anti-inflammatory moisturizing mask containing codonopsis pilosula and astragalus membranaceus and preparation method of mask | |
| CN110507558A (en) | A kind of wound repair hyaluronic acid facial mask liquid and preparation method thereof | |
| CN110787106A (en) | Plant revitalizing and purifying composition and preparation method thereof | |
| CN116549307A (en) | Nerve-soothing and soothing type eye and lip cleansing lotion and preparation method thereof | |
| CN106398878A (en) | Congealed fat essential oil handmade soap with effects of skin soothing and convergence | |
| CN114469760A (en) | Anti-hair loss composition, anti-hair loss washing and protecting product and preparation method thereof | |
| CN112022782A (en) | Whitening and blackening preventing essence and preparation method thereof | |
| CN108721186B (en) | Anti-aging face cream and preparation method thereof | |
| CN102266281A (en) | Anti-dandruff anti-itch cream shampoo | |
| CN112107494A (en) | Facial mask essence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |